InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P23
Within normal range
vs 2Y Ago
-2.7x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -43.92% |
| Q3 2025 | -26.07% |
| Q2 2025 | -7.17% |
| Q1 2025 | 33.68% |
| Q4 2024 | -36.97% |
| Q3 2024 | -77.50% |
| Q2 2024 | 46.79% |
| Q1 2024 | -6.44% |
| Q4 2023 | 16.42% |
| Q3 2023 | -195.13% |
| Q2 2023 | 55.48% |
| Q1 2023 | 39.01% |
| Q4 2022 | -20.29% |
| Q3 2022 | 43.46% |
| Q2 2022 | 24.36% |
| Q1 2022 | -49.31% |
| Q4 2021 | -33.11% |
| Q3 2021 | -20.77% |
| Q2 2021 | 52.35% |
| Q1 2021 | -156.01% |
| Q4 2020 | -31.33% |
| Q3 2020 | -10.28% |
| Q2 2020 | 15.48% |
| Q1 2020 | 28.79% |
| Q4 2019 | 12.40% |
| Q3 2019 | -23.19% |
| Q2 2019 | 10.47% |
| Q1 2019 | -65.40% |
| Q4 2018 | 2.96% |
| Q3 2018 | -34.13% |
| Q2 2018 | -46.67% |
| Q1 2018 | 14.66% |
| Q4 2017 | 27.05% |
| Q3 2017 | -31.97% |
| Q2 2017 | -11.88% |
| Q1 2017 | -15.28% |
| Q4 2016 | -287.43% |
| Q3 2016 | -73.36% |
| Q2 2016 | -58.55% |
| Q1 2016 | 42.01% |